Hi friends!!!
In our previous blogs, we have discussed about the following topics.
EU MDR Timeline, Annex, Chapter
EU MDR Post Market Surveillance
EU MDR Technical Documentation - Part 1
EU MDR Technical Documentation - Part 2
EU MDR General Safety and Performance Requirement
EU MDR Information on the Label
EU MDR Post Market Clinical Follow Up
EU MDR Unique Device Identification - Part 1
EU MDR Unique Device Identification - Part 2
EU MDR Chapter & Articles - Part 1
EU MDR 2017/745 is live now. And it the most trending topic in Medical Device Regulatory Affairs field. Most of the medical device companies are in EU MDR Transition to make sure that they can sell their products in Europe.
Therefore, it is important for Medical Device QA/RA Professionals to know in detail about EU MDR 2017/745 Chapters & Articles.
In our previous blog we discussed our Chapter I - Chapter V and its articles. Let’s discuss in detail about remaining Chapters & Articles.
Image courtesy: WikipediaLicensed under: CC Share Alike
CHAPTER VI - CLINICAL EVALUATION AND CLINICAL INVESTIGATIONS
ARTICLE 61: Clinical Evaluation
ARTICLE 62: General requirements regarding clinical
investigations conducted to demonstrate conformity of devices
ARTICLE 63: Informed Consent
ARTICLE 64: Clinical investigations on incapacitated
subjects
ARTICLE 65: Clinical investigations on minors
ARTICLE 66: Clinical investigations on pregnant or
breastfeeding women
ARTICLE 67: Additional National measures
ARTICLE 68: Clinical investigations in emergency situations
ARTICLE 69: Damage Compensation
ARTICLE 70: Application for clinical investigations
ARTICLE 71: Assessment by member states
ARTICLE 72: Conduct of Clinical Investigation
ARTICLE 73: Electronic system on clinical investigations
ARTICLE 74: Clinical investigations regarding devices
bearing the CE marking
ARTICLE 75: Substantial modifications to clinical
investigations
ARTICLE 76: Corrective measures to be taken by Member States
and information exchange between Member States
ARTICLE 77: Information from the sponsor at the end of a
clinical investigation or in the event of a temporary halt or early termination
ARTICLE 78: Coordinated assessment procedure for clinical
investigations
ARTICLE 79: Review of coordinated assessment procedure
ARTICLE 80: Recording and reporting of adverse events that
occur during clinical investigations
ARTICLE 81: Implementing acts
ARTICLE 82: Requirements regarding other clinical
investigations
CHAPTER VII - POST-MARKET SURVEILLANCE, VIGILANCE AND MARKET SURVEILLANCE
SECTION 1 – Post Market Surveillance
ARTICLE 83: Post-market surveillance system of the
manufacturer
ARTICLE 84: Post-market surveillance plan
ARTICLE 85: Post-market surveillance report
ARTICLE 86: Periodic safety update report
SECTION 2 – Vigilance
ARTICLE 87: Reporting of serious incidents and field safety
corrective actions
ARTICLE 88: Trend reporting
ARTICLE 89: Analysis of serious incidents and field safety
corrective actions
ARTICLE 90: Analysis of vigilance data
ARTICLE 91: Implementing acts
ARTICLE 92: Electronic system on vigilance and on post-market
surveillance
SECTION 3 – Market Surveillance
ARTICLE 93: Market surveillance activities
ARTICLE 94: Evaluation of devices suspected of presenting an
unacceptable risk or other non-compliance
ARTICLE 95: Procedure for dealing with devices presenting an
unacceptable risk to health and safety
ARTICLE 96: Procedure for evaluating national measures at
Union level
ARTICLE 97: Other non-compliance
ARTICLE 98: Preventive health protection measures
ARTICLE 99: Good Administrative practice
ARTICLE 100: Electronic system on market surveillance
CHAPTER VIII - COOPERATION BETWEEN MEMBER STATES, MEDICAL DEVICE COORDINATION GROUP, EXPERT LABORATORIES, EXPERT PANELS AND DEVICE REGISTERS
ARTICLE 101: Competent authorities
ARTICLE 102: Cooperation
ARTICLE 103: Medical Device Coordination Group
ARTICLE 104: Support by the commission
ARTICLE 105: Tasks of the MDCG
ARTICLE 106: Provision of scientific, technical and clinical
opinions and advice
ARTICLE 107: Conflict of interests
ARTICLE 108: Device registers and databanks
CHAPTER IX - CONFIDENTIALITY, DATA PROTECTION, FUNDING AND PENALTIES
ARTICLE 109: Confidentiality
ARTICLE 110: Data protection
ARTICLE 111: Levying of fees
ARTICLE 112: Funding of activities related to designation
and monitoring of notified bodies
ARTICLE 113: Penalties
CHAPTER X – FINAL PROVISIONS
ARTICLE 114: Committee procedure
ARTICLE 115: Exercise of the delegation
ARTICLE 116: Separate delegated acts for different delegated
powers
ARTICLE 117: Amendment to Directive 2001/83/EC
ARTICLE 118: Amendment to Regulation (EC) No 178/2002
ARTICLE 119: Amendment to Regulation (EC) No 1223/2009
ARTICLE 120: Transitional provisions
ARTICLE 121: Evaluation
ARTICLE 122: Repeal
ARTICLE 123: Entry into force and date of application
Now I hope you have acquired some knowledge about EU MDR 2017/745 Chapters & Articles.
NOTE: Dear friends!!!... Please do comment a topic related to Biomedical, so that we can discuss it in future blogs.
Check out for this blog about Computed Tomography, X ray, MRI scan, ECG.
COMPUTED TOMOGRAPHY|TECHNOLOGY|ARTIFACTS
x ray machine working principle
DON’T FORGET TO FOLLOW THIS BLOG PAGE
DROP YOUR MAIL ID TO GET IMMEDIATE UPDATES
If you find this blog post knowledgeable,
comment & share it with a friend!